Key result
Remnant lipoproteins represent dynamic prolonged-residence states rather than fixed particle classes.
Why the study?
The definition of remnant lipoproteins remains heterogeneous and incompletely resolved, limiting understanding of their atherogenic role and metabolic dynamics.
Proposes a residence time-based conceptual framework for remnant lipoproteins, emphasizing dynamic metabolic states over fixed particle classes to better understand atherogenesis and residual cardiovascular risk.
Inconsistent remnant definitions caution against direct clinical use; leaves open standardized assays for TRL risk research.
Remnant lipoproteins are recognized as atherogenic derivatives of triglyceride-rich lipoproteins (TRLs). However, the definition of "remnants" remains heterogeneous and incompletely resolved. Remnants have been regarded as partially lipolyzed intermediates generated during lipoprotein lipase (LPL)-mediated metabolism of chylomicrons and very-low-density lipoproteins (VLDLs). Current operational definitions vary and include ultracentrifugation-defined fractions (IDLs), remnant-like lipoprotein particles (RLPs), remnant cholesterol (RC), and apolipoprotein-defined subclasses. These approaches identify overlapping yet compositionally heterogeneous particles. Here, we propose that remnant lipoproteins should be conceptualized not as fixed particle classes, but as dynamic metabolic states arising during delayed TRL clearance. The defining characteristic of a remnant is prolonged intravascular residence time rather than density, size, or apolipoprotein composition alone. Physiological "nascent remnants" generated during normal postprandial metabolism are rapidly cleared through apoE-mediated hepatic uptake pathways, whereas metabolically "retained remnants" persist within the circulation and undergo lipolytic remodeling, oxidative modification, endothelial interaction, and acquisition of atherogenic potential. We further discuss how imbalance between TRL influx and TRL-processing reserve may contribute to remnant retention and metabolic disease. In this context, circulating intact lipoprotein lipase (intact LPL), representing structurally preserved full-length LPL, may provide a functional window into systemic TRL-processing capacity. The TG/intact LPL ratio may serve as a surrogate reflecting imbalance between TRL burden and lipolytic processing reserve. This residence time-based framework may help integrate observations across postprandial lipemia, obesity-associated dyslipidemia, multifactorial chylomicronemia syndrome, and residual cardiovascular risk. More broadly, this perspective shifts the conceptual focus of remnant biology from static particle classification toward dynamic metabolic processing within the TRL cascade.
No takes yet. Share an insight, caveat, or question.
Nakajima et al. (2026) conducted a review in Metabolic disease and dyslipidemia. Residence time-based framework for remnant lipoproteins was evaluated. Remnant lipoproteins should be conceptualized as dynamic metabolic states defined by prolonged intravascular residence time rather than fixed particle classes based on density or composition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: